Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Why Entrepreneurs Should Care about Provisions that Only Directly Impact the Investors

This article was originally published in Start Up

Executive Summary

Financing provisions that appear to only directly affect the various series of preferred stock can in fact impact the company's operations somewhere down the line. Such is the case with pay-to-play, voting rights, and a right of first refusal among investors.

You may also be interested in...



VC Term Sheets: Why We're so Pro on Anti-Dilution.

A VC's perspective on anti-dilution, an often convenient, and sometimes investment saving deal provision.

VC Term Sheets: Liquidation Preference and Participating Preferred

Arthur Klausner discusses liquidation and participating preferred stock in the third part of his series on VC term sheets.

Inside the Term-Sheet Mindset of a Life Sciences VC

When deal discussions get tough and there seems to be no way to cross the chasm between the entrepreneur's valuation expectations and the VC's choking point, the savvy professional investor will likely find a way to slant the secondary terms in order to achieve a deal that works.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC091042

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel